![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Różański J. Wójcicki J. Gawrońska-Szklarz B. Musial H.D. Millo B. Dutkiewicz G.
Publisher: Taylor & Francis Ltd
ISSN: 1060-4456
Source: Pharmacology Communications, Vol.12, Iss.3, 2002-07, pp. : 179-187
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Primary brain tumors, delta 24 and tumor metabolism
Expert Review of Neurotherapeutics, Vol. 13, Iss. 4, 2013-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drug Treatment of Combined Hyperlipidemia
American Journal of Cardiovascular Drugs, Vol. 1, Iss. 5, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs for hyperlipidemia
By Paras Christos Hussain M Mahmood Rosenson Robert S
Expert Opinion on Emerging Drugs, Vol. 15, Iss. 3, 2010-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Genetically defined hyperlipidemia
By Smit Jan WA Diamant Michaela
Pharmacogenomics, Vol. 5, Iss. 3, 2004-04 ,pp. :